Endometrial Cancer
A Phase III, randomized, multi-site, open-label trial of BNT323/DB-1303 versus investigators choice of chemotherapy in previously treated patients with HER2-expressing recurrent endometrial cancer (BNT323-01)
- Details
ClinicalTrials.gov ID:
NCT06340568
Diagnosis Type:
NA
USOR Number:
- Address
,
P: